vs

Side-by-side financial comparison of Dexcom (DXCM) and TWILIO INC (TWLO). Click either name above to swap in a different company.

TWILIO INC is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× Dexcom). Dexcom runs the higher net margin — 21.2% vs 6.4%, a 14.8% gap on every dollar of revenue. Over the past eight quarters, TWILIO INC's revenue compounded faster (14.0% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Twilio Inc. is an American cloud communications company based in San Francisco, California, which provides programmable communication tools for making and receiving phone calls, sending and receiving text messages, and performing other communication functions using its web service APIs.

DXCM vs TWLO — Head-to-Head

Bigger by revenue
TWLO
TWLO
1.1× larger
TWLO
$1.4B
$1.3B
DXCM
Higher net margin
DXCM
DXCM
14.8% more per $
DXCM
21.2%
6.4%
TWLO
Faster 2-yr revenue CAGR
TWLO
TWLO
Annualised
TWLO
14.0%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
TWLO
TWLO
Revenue
$1.3B
$1.4B
Net Profit
$267.3M
$90.0M
Gross Margin
62.9%
48.6%
Operating Margin
25.6%
7.7%
Net Margin
21.2%
6.4%
Revenue YoY
21.6%
Net Profit YoY
153.6%
EPS (diluted)
$0.67
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
TWLO
TWLO
Q1 26
$1.3B
$1.4B
Q4 25
$1.3B
$1.4B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.2B
Q1 25
$1.0B
$1.2B
Q4 24
$1.1B
$1.2B
Q3 24
$994.2M
$1.1B
Q2 24
$1.0B
$1.1B
Net Profit
DXCM
DXCM
TWLO
TWLO
Q1 26
$267.3M
$90.0M
Q4 25
$267.3M
$-45.9M
Q3 25
$283.8M
$37.2M
Q2 25
$179.8M
$22.4M
Q1 25
$105.4M
$20.0M
Q4 24
$151.7M
$-12.5M
Q3 24
$134.6M
$-9.7M
Q2 24
$143.5M
$-31.9M
Gross Margin
DXCM
DXCM
TWLO
TWLO
Q1 26
62.9%
48.6%
Q4 25
62.9%
48.5%
Q3 25
60.5%
48.6%
Q2 25
59.5%
49.1%
Q1 25
56.9%
49.6%
Q4 24
58.9%
50.2%
Q3 24
59.7%
51.0%
Q2 24
62.4%
51.3%
Operating Margin
DXCM
DXCM
TWLO
TWLO
Q1 26
25.6%
7.7%
Q4 25
25.6%
4.2%
Q3 25
20.1%
3.1%
Q2 25
18.4%
3.0%
Q1 25
12.9%
2.0%
Q4 24
17.0%
1.1%
Q3 24
15.3%
-0.4%
Q2 24
15.7%
-1.8%
Net Margin
DXCM
DXCM
TWLO
TWLO
Q1 26
21.2%
6.4%
Q4 25
21.2%
-3.4%
Q3 25
23.5%
2.9%
Q2 25
15.5%
1.8%
Q1 25
10.2%
1.7%
Q4 24
13.6%
-1.0%
Q3 24
13.5%
-0.9%
Q2 24
14.3%
-2.9%
EPS (diluted)
DXCM
DXCM
TWLO
TWLO
Q1 26
$0.67
$0.57
Q4 25
$0.67
$-0.28
Q3 25
$0.70
$0.23
Q2 25
$0.45
$0.14
Q1 25
$0.27
$0.12
Q4 24
$0.37
$-0.10
Q3 24
$0.34
$-0.06
Q2 24
$0.35
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
TWLO
TWLO
Cash + ST InvestmentsLiquidity on hand
$917.7M
$542.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$7.8B
Total Assets
$6.3B
$9.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
TWLO
TWLO
Q1 26
$917.7M
$542.0M
Q4 25
$917.7M
$682.3M
Q3 25
$1.8B
$734.8M
Q2 25
$1.2B
$969.2M
Q1 25
$904.9M
$467.1M
Q4 24
$606.1M
$421.3M
Q3 24
$621.2M
$584.0M
Q2 24
$939.2M
$755.1M
Total Debt
DXCM
DXCM
TWLO
TWLO
Q1 26
Q4 25
$992.3M
Q3 25
$991.9M
Q2 25
$991.4M
Q1 25
$991.0M
Q4 24
$990.6M
Q3 24
$990.2M
Q2 24
$989.8M
Stockholders' Equity
DXCM
DXCM
TWLO
TWLO
Q1 26
$2.7B
$7.8B
Q4 25
$2.7B
$7.8B
Q3 25
$2.7B
$7.9B
Q2 25
$2.6B
$8.0B
Q1 25
$2.3B
$8.0B
Q4 24
$2.1B
$8.0B
Q3 24
$2.0B
$8.2B
Q2 24
$2.4B
$8.7B
Total Assets
DXCM
DXCM
TWLO
TWLO
Q1 26
$6.3B
$9.6B
Q4 25
$6.3B
$9.8B
Q3 25
$7.5B
$9.7B
Q2 25
$7.3B
$9.8B
Q1 25
$6.8B
$9.8B
Q4 24
$6.5B
$9.9B
Q3 24
$6.4B
$10.0B
Q2 24
$6.8B
$10.5B
Debt / Equity
DXCM
DXCM
TWLO
TWLO
Q1 26
Q4 25
0.13×
Q3 25
0.13×
Q2 25
0.12×
Q1 25
0.12×
Q4 24
0.12×
Q3 24
0.12×
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
TWLO
TWLO
Operating Cash FlowLast quarter
$153.0M
Free Cash FlowOCF − Capex
$132.0M
FCF MarginFCF / Revenue
9.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.70×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
TWLO
TWLO
Q1 26
$153.0M
Q4 25
$294.0M
$271.6M
Q3 25
$659.9M
$263.6M
Q2 25
$303.0M
$277.1M
Q1 25
$183.8M
$191.0M
Q4 24
$301.4M
$108.4M
Q3 24
$199.5M
$204.3M
Q2 24
$279.4M
$213.3M
Free Cash Flow
DXCM
DXCM
TWLO
TWLO
Q1 26
$132.0M
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
DXCM
DXCM
TWLO
TWLO
Q1 26
9.4%
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
DXCM
DXCM
TWLO
TWLO
Q1 26
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
DXCM
DXCM
TWLO
TWLO
Q1 26
1.70×
Q4 25
1.10×
Q3 25
2.33×
7.08×
Q2 25
1.69×
12.36×
Q1 25
1.74×
9.54×
Q4 24
1.99×
Q3 24
1.48×
Q2 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons